Cure My Disease

Don't miss your cure!

 Log in / Sign up

New tool aims to better measure breathlessness in lung patients

NCT ID NCT02229994

Completed Knowledge-focused Sponsor: Assistance Publique - Hôpitaux de Paris Source: ClinicalTrials.gov ↗

First seen Jun 26, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This study tested a new self-administered questionnaire called DYSLIM to measure shortness of breath and its impact on daily life in people with chronic respiratory diseases like COPD, cystic fibrosis, and pulmonary hypertension. Researchers enrolled 199 participants to check if the questionnaire is reliable and accurate. The goal is to give doctors a simple, practical tool to assess breathlessness in routine care.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

What this could lead to

If successful, this could give doctors a better tool to measure and track shortness of breath in patients with chronic lung diseases.

What could go wrong

This is an early-stage study focused on developing a questionnaire, not testing a treatment. It may not lead to immediate changes in patient care.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for COPD (WITH - WITHOUT REHABILITATION) are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

chronic obstructive pulmonary disease COPD, severe early onset cystic fibrosis Dyspnea interstitial lung disease Neoplasm Metastasis pulmonary arterial hypertension

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

COPD (WITH - WITHOUT REHABILITATION) CYSTIC FIBROSIS OF THE ADULT DIFFUSE INTERSTITIAL LUNG DISEASES PULMONARY ARTERIAL HYPERTENSION PRIMARY OR SECONDARY (POST EMBOLIC .....)

Contacts and locations

Locations

  • Service de Pneumologie AP-HP, Hôpitaux Universitaires Paris Centre

    Paris, 75006, France